IRADIMED CORPORATION (IRMD)

NGM – Real vaqt narxi. Valyuta: USD

93.96

+0.09 (0.10%)

Yopilishda: Jun 26, 2026, 4:00 PM EDT

93.96

-0.00 (-0.00%)

Bozordan keyin: Jun 26, 2026, 4:31 PM EDT

20.05.2026

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.

01.05.2026

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

01.05.2026

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

iRadimed (IRMD) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.42 per share a year ago.

27.04.2026

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

ORLANDO, Fla., April 27, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 first quarter financial results before the market opens on Friday, May 1, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

10.04.2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.

23.03.2026

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

GMED, TCMD and IRMD tap GenAI to boost diagnostics and workflows, but high costs, regulation gaps and macro pressures still weigh on MedTech growth.

16.03.2026

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference.

Videolar

No Data

There is no data to display

Press-relizlar

10.04.2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

ORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference.

16.03.2026

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that it will participate in the 38 th Annual Roth Conference.

10.02.2026

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance imaging (“MRI”) compatible medical devices and products. The Company is a provider of (i) non-magnetic intravenous (“IV”) infusion pump systems and (ii) non-magnetic patient vital signs monitoring systems that are each designed for use during MRI procedures.

08.12.2025

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50 per share of the Company's outstanding common stock. This special cash dividend is payable on December 30, 2025, to stockholders of record at the close of business on December 17, 2025. The Company is a leader in developing innovative magnetic resonance imaging (“MRI”) compatible medical devices and products. The Company produces the only known non-magnetic intravenous (“IV”) infusion pump system and a non-magnetic patient vital signs monitoring system designed for use during MRI procedures.

IRADIMED CORPORATION (IRMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

Videolar

No Data

Press-relizlar

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

Videolar

No Data

Press-relizlar

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

Search stocks

IRADIMED CORPORATION (IRMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

IRADIMED CORPORATION (IRMD)

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

Videolar

No Data

Press-relizlar

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

IRADIMED CORPORATION (IRMD) Q1 2026 Earnings Call Transcript

iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates

IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

Videolar

No Data

Press-relizlar

IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference

IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

IRADIMED Announces Special Cash Dividend of $0.50 Per Share